NVCR
NovoCure Limited Ordinary Shares
Healthcare •
Medical Devices •
stocks •
XNAS
• usd
$11.56
$-0.28
(-2.36%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.29B | EPS (ttm) | $-1.61 | Current Price | $11.56 |
| Enterprise Value | $1.06B | Forward EPS | $-1.49 | Previous Close | $11.84 |
| P/E Ratio | - | ROA | -8.30% | 52W High | $24.73 |
| Forward P/E | -7.76 | ROE | -50.60% | 52W Low | $10.70 |
| PEG Ratio | - | Gross Margin | 75.53% | 50 Day Avg | $13.00 |
| P/S Ratio | 2.02 | Operating Margin | -21.54% | 200 Day Avg | $14.27 |
| P/B Ratio | 3.79 | Profit Margin | -27.66% | Volume | 1.58M |
| EV/EBITDA | -6.65 | Current Ratio | 1.55 | Avg Volume | 1.52M |
| EV/Sales | 1.65 | Quick Ratio | 1.49 | Beta | 0.73 |
| Employees | 1.49K | Debt/Equity | 233.77 | Shares Outstanding | 111.98M |
| Sector | Healthcare | Total Debt | $797.94M | Float Shares | 91.40M |
| Industry | Medical Devices | Total Cash | $1.03B | Short Float | 10.48% |
| Optionable | Yes | Cash/Share | $9.23 | Short Ratio | 5.64 |
| Dividend Yield | - | Book Value/Share | $3.05 | % Held by Insiders | 9.81% |
| Target Price | $24.07 | Revenue (TTM) | $642.27M | % Held by Institutions | 84.07% |